Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
COLL: Collegium Pharmaceutical, Inc. Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
COLL
The Story
COLL
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+11.4% / yr
Operating margin
23.8%
ROIC
10.5%
Financially safe
Stretched
Debt / equity
2.59×
Interest coverage
1.2×
Current ratio
1.71×
Valuation
Unrated
P/E ratio
14.9×
Collegium Pharmaceutical, Inc.
COLL
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Collegium Pharmaceutical, Inc.
COLL
NASDAQ
·
USD
·
Closed
$35.39
−1.64%
$35.39
−$0.59 (1.64%)
52W Range
29th
pctl
Volume
0.62×
avg
Mkt Cap
1.15B
USD
P/E
14.9
TTM
Div Yield
–
ann
52W Range
29th
pctl
Volume
0.62×
avg
Market Cap
1.15B
USD
P/E Ratio
14.9
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings